Parent training intervention leads to significant improvement in sleep problems
Image content: This image is available to view online.
View image online (https://assets.clevelandclinic.org/transform/3fd4ab52-3f72-4659-b0ac-eebceb715bde/child-restless-legs-1133834719)
Sleeping child
Up to 80% of children with autism spectrum disorder (ASD) also have at least moderate sleep disturbances. Disordered sleep in children with autism can amplify already delayed social interactions, repetitive behaviors, affective problems, inattention/hyperactivity and irritability.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
In a prior NIH-funded study (R34MH082882), the principal investigator, Cynthia R. Johnson, PhD, Director of the Cleveland Clinic Children’s Center for Autism, showed that a five-session, individually delivered parent training intervention for young children with ASD and sleep disturbances resulted in significant improvements in sleep problems compared with the control group, which received five sessions of an education program relevant to young children with ASD.1
This study was delivered in a tertiary, specialized setting requiring parents to make many trips to an urban area; some families traveled over two hours to participate. Now, with funding from the Department of Defense, Dr. Johnson and her team will further test this manualized parent training program specifically targeting bedtime and sleep disturbance but delivered via a telehealth platform. This four-year randomized control trial is actively recruiting (email autismresearch@ccf.org for more information). If we demonstrate that this manualized parent training program specifically targeting sleep disturbances can be delivered with fidelity and efficacy via a telehealth platform, this has broad implications for clinical service delivery to reach children and families living at a distance from a specialized autism center.
Advertisement
Advertisement
Emerging insights underscore a need to look beyond seizures alone
Phase 1 trial of azer-cel reports good preliminary safety and efficacy
Physical, occupational and speech therapists will provide state-of-the-art outpatient care
Milestone case report expands understanding of infectious risks for those on immunomodulatory therapies
Advanced technologies are changing expectations about what’s possible
A rare opportunity to design for speed, care coordination, recovery and continuous monitoring
Multidisciplinary, proactive approach also improved discharge outcomes
Phase 1 Breakfree-2 trial reports good safety and efficacy at week 26